sec filing
XC
NASDAQ · XCUR
Exicure, Inc.
Healthcare · Biotechnology
$1.01
Up+$0.08 (+8.04%)
Updated Nov 2, 2026, 10:28 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 39.07M
- P/E ratio
- -4.91
- Dividend yield
- 0.00%
- 52-week range
- $0.88 – $9.48
- Volume
- 29.57K
- Avg. volume
- 653.33K
Price performance · XCUR
XCUR price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
XCUR closed at $1.01 after 20 trading sessions, down 5.61% for the selected period.
- Last close
- $1.01
- Period change
- -5.61%
- Period low
- $0.93
- Period high
- $1.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $0.9438 | $1.06 | $0.9438 | $1.01 | 29.57K |
| Oct 29, 2026 | $1.05 | $1.09 | $0.8752 | $0.9348 | 41.44K |
| Oct 28, 2026 | $1.08 | $1.13 | $1.01 | $1.0165 | 25.24K |
| Oct 27, 2026 | $1.10 | $1.10 | $1.03 | $1.07 | 12.33K |
| Oct 26, 2026 | $1.06 | $1.09 | $1.02 | $1.09 | 36.11K |
| Oct 23, 2026 | $1.10 | $1.14 | $1.04 | $1.05 | 61.29K |
| Oct 22, 2026 | $1.15 | $1.28 | $1.0801 | $1.13 | 439.97K |
| Oct 21, 2026 | $0.9841 | $1.05 | $0.9705 | $1.01 | 40.66K |
| Oct 20, 2026 | $1.11 | $1.11 | $0.9901 | $0.9987 | 47.86K |
| Oct 19, 2026 | $1.12 | $1.30 | $1.0294 | $1.03 | 69.15K |
| Oct 16, 2026 | $1.2144 | $1.2144 | $1.08 | $1.12 | 38.53K |
| Oct 15, 2026 | $1.21 | $1.24 | $1.10 | $1.12 | 20.66K |
| Oct 14, 2026 | $1.16 | $1.26 | $1.16 | $1.21 | 28.35K |
| Oct 13, 2026 | $1.12 | $1.21 | $1.09 | $1.15 | 29.66K |
| Oct 12, 2026 | $1.09 | $1.10 | $1.06 | $1.09 | 15.3K |
| Oct 9, 2026 | $0.95 | $1.10 | $0.936 | $1.05 | 316.53K |
| Oct 8, 2026 | $0.99 | $1.05 | $0.99 | $1.00 | 14.84K |
| Oct 7, 2026 | $1.04 | $1.04 | $1.00 | $1.02 | 9.23K |
| Oct 6, 2026 | $1.11 | $1.11 | $1.0701 | $1.08 | 7.34K |
| Oct 5, 2026 | $1.14 | $1.19 | $1.07 | $1.07 | 18.15K |
Latest XCUR news
The latest Smart Investors Daily articles mentioning XCUR.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…